Literature DB >> 10606183

Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.

G Soda1, A Antonaci, D Bosco, S Nardoni, M Melis.   

Abstract

The study was carried out on 53 patients who had thyroid cancer with various degree of differentiation. We studied the expression of bcl-2, a-erbB-2, p53, and p21 ras protein. The protein encoded by bCL-2 proto-oncogene is implicated in the prolongation of cell survival by blocking programmed cell death, i.e. apoptosis. The role of p53 and bcl-2 genes in the regulation of apoptosis has important implications in oncogenesis. Wild-type p53 is thought to promote apoptosis, whilst mutant p53 has a similar effect on apoptosis as bcl-2 that is inhibition of programmed cell kinase activity. C-erb-2 protein overexpression is currently being evaluated as a potential risk factor in breast cancer patients? The ras gene family codes for a 21 kD protein (p21), which binds guanine nucleotides and possesses GTPase activity. Through this mechanism, the ras p21 protein participates in the control of cell proliferation, possibly as a signal transducer from cell surface receptors to the nucleus. Activation of ras genes has been implicated in neoplastic transformation of cells. The aim of our study is to evaluate the expression of these markers in thyroid carcinomas. All immunohistochemical study was performed in paraffin-embedded tissues pathology specimen. Any well differentiated tumor in our study was positive for bcl-2 protein. C-erb-2 immunostaining was present in tumor samples in 60% of cases. In most cases, specific membrane staining as well as a weak cytoplasmic positivity of tumor cells were seen. Immunoreactivity for p53 was positive only in 10% of cases. By immunostaining, p21 protein was expressed in 55% of the 53 tumors tested, with different degree of expression. Only some poorly differentiated tumours were positive for bcl-2, furthermore all markers tested were strongly positive in these tumours. In conclusion, our results indicate that bcl-2, c-erbB-2, p53, and p21 ras protein are differently expressed in thyroid carcinomas in relation to the degree of aggressiveness and differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606183

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  5 in total

1.  Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors.

Authors:  Cinzia Azzoni; Lorena Bottarelli; Stefano Cecchini; Costanza Lagrasta; Silvia Pizzi; Tiziana D'Adda; Elisa Tamburini; Guido Rindi; Cesare Bordi
Journal:  Virchows Arch       Date:  2011-03-29       Impact factor: 4.064

2.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07

3.  Association of genetic markers in the BCL-2 family of apoptosis-related genes with endometrial cancer risk in a Chinese population.

Authors:  Tsogzolmaa Dorjgochoo; Yong-Bing Xiang; Jirong Long; Jiajun Shi; Sandra Deming; Wang-Hong Xu; Hui Cai; Jiarong Cheng; Qiuyin Cai; Wei Zheng; Xiao-Ou Shu
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 4.  Mitochondrial dysfunction in cancer.

Authors:  Kinga Księżakowska-Łakoma; Monika Żyła; Jacek R Wilczyński
Journal:  Prz Menopauzalny       Date:  2014-05-21

5.  The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells.

Authors:  Martina Broecker-Preuss; Nina Becher-Boveleth; Stefan Müller; Klaus Mann
Journal:  Cancer Cell Int       Date:  2016-04-02       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.